-
Tardive Dystonia Successfully treated with DBS
-
Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson’s Disease
-
Task based profiles of language impairment in Parkinson’s Disease
-
Tau Neuropathology Associates with In Vivo Patterns of Neurodegeneration in Lewy Body Disorders
-
TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease
-
Technology-based therapy response and prognostic biomarkers in Parkinson’s disease: results from a prospective evaluation of a de novo PD patients’ cohort
-
Temporal characterization of motor, gastrointestinal, and behavioral symptoms in a SNCA A53T transgenic mouse model of Parkinson’s disease
-
Temporal properties of resting-state functional MRI are associated with ON/OFF levodopa MDS-UPDRS III scores in patients with Parkinson’s disease
-
Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism
-
Test-Retest Reliability of Sensor-Based Telemonitoring of Parkinsonian Gait at Home
-
TET2-mediated Cdkn2A DNA hydroxymethylation in dopaminergic neuronal injury of Parkinson’s disease
-
Thalamic Deep Brain Stimulation for Acquired Dystonia in Children and Young Adults: A Phase I Clinical Trial
-
Thalamic deep brain stimulation improves tremor and spatio-temporal characteristics of gait in medically refractory orthostatic tremor
-
Thalamic nuclei volumes and intrinsic thalamic network in motor subtype in Parkinson’s disease
-
The ‘A’ in the A/T/N Alzheimer’s Disease Biomarker Classification Predicts Cognitive Outcomes in Parkinson’s Disease
-
The Accreditation and Certification of the Movement Disorders Subspecialty: A Five-Year Follow-Up Study
-
The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson’s disease: A pilot study
-
The ADNPC-RS: a risk score that identifies Lewy body disease individuals at risk for developing concomitant Alzheimer’s pathology
-
The association between thinning of cerebral cortex and age of onset in Parkinson’s disease
-
The Association of Taichi to Delayed Progression of Parkinson’s Disease
-
The Benchmark Clinic: A Comprehensive Care Model for People with Parkinson’s Disease
-
The Care Partner Perspective: Most Challenging Parkinson’s Symptoms
-
The clinical features of non-motor symptoms in Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder(RBD)
-
The clinical features, treatments and genetic characteristics in Chinese children with dopa-responsive dystonia
-
The Clinical Heterogeneity of Orthostatic Hypotension in PD Patients
-
The clinical significance of the swallow tail sign in distinguishing Parkinson’s disease patients from healthy individuals
-
The clinical spectrum of movement disorders associated with neuronal antibodies
-
The clinical utility of programming method for multi-contact electrodes of deep brain stimulation in Parkinson’s disease
-
The Cognitive Training In Parkinson Study (COGTIPS), a randomized controlled trial
-
The cold hand sign in multiple system atrophy: prevalence, associated factors and impact on survival
-
The development and application of an adjunct genetic counseling pre-test assessment and video intervention for Parkinson’s disease (PD)
-
The diagnostic value of smartphone-based instrumented Timed Up & Go test in different movement disorders
-
The distinct EEG signature of celiac disease-related cortical myoclonus
-
The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features
-
The dysfunctional autonomic function and “dysfunctional” fatigue in drug naïve Parkinson’s disease
-
The Dystonia Coalition Natural History Project: An Available Research Resource
-
The effect of botulinum toxin A on pain associated with cervical dystonia (CD) in routine clinical practice
-
The effect of comorbid NPH on the clinical feature and progression of Parkinson’s disease
-
The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions
-
The effect of exercise on pain in Parkinson’s disease: A protocol for a systematic review
-
The effect of levodopa and cognitive-motor dual interference on gait parameters in PD FOG
-
The Effect of Rasagiline on Motor and Non-Motor Symptoms in Parkinson’s Disease
-
The effect of severity of Parkinson’s disease on chronic headache
-
The Efficacy of Teleconsultation for Management of Movement Disorders in Thailand
-
The efficacy of traditional Mikkyo Buddhism meditation in stress management of Parkinson’s syndrome patients
-
The exosomal a-syn filaments can be a novel biomarker of Parkinson’s disease
-
The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data
-
The feasibility of detailed phenotyping of muscle mitochondrial respiratory chain function and content in Parkinson’s disease
-
The Feasibility of Using of the Non-Medication in the Treatment of Post-Stroke Vascular Parkinsonism
-
The First-Ever CNV Analysis in Latin American Parkinson’s Disease Patients
-
The Fragile X Mental Retardation Protein is lost prior to the appearance of Lewy pathology in Parkinson’s disease
-
The Future of Hospitalization for People with Parkinson’s Disease
-
The genetic study of autosomal dominant spinocerebellar ataxia in Kazakhstan
-
The genetic study of hereditary chorea in Kazakhstan
-
The Gut Dysmotility Questionnaire (GDQ) for Parkinson’s disease: current development
-
The Impact of Antipsychotic Dose Reduction Within a Medicare Population
-
The impact of anxiety on social functioning in Parkinson’s disease
-
The impact of motor and non-motor symptoms on walking capacity in people with Parkinson’ disease
-
The Impact of the Sensory Trick on Gating Multimodal Afferents in Cervical Dystonia
-
The incidence, predictors, and outcomes of delirium in Parkinson’s disease and atypical parkinsonism
-
The Indian Experience of Continuous Dopaminergic therapy with Apomorphine in Parkinson’s Disease
-
The Influence of 3-Phenoxybenzoic Acid in Dopaminergic Degeneration
-
The influence of ANNK1/DRD2 haplotypes on the onset of complications of long-term levodopa therapy in Parkinson’s disease
-
The interaction of Parkin and TAF15 for the Drosophila in which neuronal defect was induced
-
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset
-
The Levodopa in Early Parkinson’s disease (LEAP) study: Post-hoc analyses
-
The Many Faces of Bradykinesia in Parkinson’s Disease : The Quantitative Analysis from A Keyboard Typing Test
-
The non-declaration of musculoskeletal pain in Parkinson’s disease in patient-related outcome measures –The King’s experience
-
The pathophysiology of dystonic tremors and comparison with essential tremor
-
The Personalized Parkinson Project – data quality enhancing strategies
-
The Phenotypical Presentation of SCA8 in Taiwan
-
The Presence of Efferent Brain-Gut Neuropathy Correlates with Severe Constipation in Parkinson’s disease
-
The Progressive Supranuclear Palsy Clinical Deficits Scale
-
The relationship between MIBG myocardial scintigraphy and clinical factors in multiple system atrophy
-
The Relationship Between Modified Four Square Step Test (mFSST) and Outcome Measures Related to Fall Risk and Quality of Life in Individuals with Parkinson’s Disease
-
The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease
-
The relationship between REM sleep behavior disorder and cognitive impairment in drug-naïve Parkinson’s disease
-
The relationship between serum uric acid and depression in patients with essential tremor
-
The role of attention networks in walking in Parkinson’s disease
-
The role of dementia in Parkinson’s disease
-
The Role of Directional Configuration for Essential Tremor: A Single Center Experience
-
The role of dopamine mis-metabolism in preclinical Parkinson’s disease olfactory deficits
-
The role of low contrast visual acuity in cognitive performance in Lewy body diseases
-
The role of peripheral T- and B-lymphocytes in LRRK2-mediated Parkinson’s disease
-
The role of polymorphic allelic variants of the VEGFα and TGFβ gene in the development of cerebrovascular disorders in patients with metabolic syndrome
-
The role of the disorders in interaction between visual and oculomotor systems and their MRI correlation in patients with camtocormia in Parkinson’s disease
-
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntington’s disease pathogenesis
-
The ROPAD (Rostock International Parkinson’s Disease Study) study: Towards defining the genetic epidemiology of the disease
-
The severity and distribution of tau pathology distinguish corticobasal degeneration and progressive supranuclear palsy
-
The short- and long-term outcomes of STN DBS in PD patients with or without RBD
-
The sooner, the better: early diagnosis and treatment in functional neurological disorders
-
The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease: a pilot study
-
The Subthalamic Fasciculus and Connectivity Profiling of Stimulation-induced Dyskinesia following Pallidal DBS in Parkinson’s Disease
-
The Unique Voiceprint Changed In Parkinson’s Disease
-
The UP study – Ursodeoxycholic acid (UDCA) as neuroprotective treatment for Parkinson’s disease
-
The use of Virtual Reality to Assess the Quality of Life in Patients with Spinocerebellar Ataxia
-
The usefulness of a dual-phase 18-F-FP-CIT PET in a case of Alzheimer’s disease with slow movement
-
The utility of single dose levodopa challenges in the management of Parkinson’s disease
-
The variants of autophagy genes of early-onset Parkinson’s disease
-
Therapeutic Benefits of Music for Three Types of Neurological Disorders: an fNIRS Study Protocol for Controlled Trial in Dalian, China, Part 1-Parkinson’s Disease
-
Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador
-
Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes
-
Three-year safety and clinical outcomes from the PD-1101 trial of AADC gene therapy for advanced Parkinson’s disease
-
Time matters in brain health: how can health systems respond to the growing demand for genetic testing?
-
Time Series Analysis Applied to EEG Shows Increased Global Connectivity During Motor Activation in PD Patients Compared to Controls
-
Topographical subtypes of multiple system atrophy: MRI and PET studies
-
Toward the digitization of the International Parkinson and Movement Disorder Society rating scales
-
Towards a method for accurate detection of diphasic dyskinesia
-
Towards a scoring system to distinguish early parkinsonian variant of multiple system atrophy from Parkinson’s disease
-
Tractography of the corticospinal tract in Parkinson’s disease. How does diffusion values vary along tract segments?
-
Trajectories of pain in newly diagnosed Parkinson’s disease
-
Transcranial brain sonography can distinguish drug induced parkinsonism from idiopathic Parkinson’s disease in Korean?
-
Transcranial direct current stimulation over the supplementary motor area in Tourette syndrome: Preliminary findings of a randomized controlled trial
-
Transcranial sonography in HIV infection: Does it reflect infectious and neurological symptoms?
-
Transcutaneous magnetic spinal cord stimulation for freezing of gait in Parkinson’s disease (PD)
-
Transcutaneous spinal cord current stimulation modulate Reactive Oxygen Species (ROS) in multiple sclerosis patients
-
Translatable biomarkers in gene therapy for Huntington’s Disease: learnings from pre-clinical studies
-
Treatment characterization and decision-making strategy for first-line pharmacological motor symptomatic therapies in Parkinson’s disease
-
Treatment of hemichorea-hemiballism with valbenazine
-
Treatment of medically refractory orthostatic tremor: deep brain stimulation of bilateral thalamic ventral intermediate nucleus with sustained symptomatic improvement
-
Treatment of Medication-Refectory Holmes Tremor by Simultaneous Thalamic Ventral Intermediate (VIM) Nucleus and Subthalamic Nucleus (STN) Deep Brain Stimulation-A Case Report
-
Treatment of Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy (MSA) with a wearable Pneumatic Compression Garment utilising Soft Robotics
-
Treatment with Botulinum Toxin for Refractory Fever caused by Severe Spasticity
-
Tremor-dominant cervical dystonia and the cerebellum: lessons from saccade adaptation
-
Trends and Racial Disparities of Palliative Care Use among Hospitalized Patients with Parkinson’s Disease
-
Triggers and Alleviating Factors for Fatigue in Parkinson’s Disease
-
Twiddler’s Syndrome in Deep Brain Stimulation
-
Two cases of Ataxia Telangiectasia Like Disorder: phenotypic spectrum associated with MRE11 gene
-
Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease
-
Type-3 Metabotropic Glutamate Receptors and Parkinson’s Disease: Preclinical Studies and Human Genetics
-
Types of Pain in Parkinson`s Disease Patients
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org